Big Gain For Liminatus Pharma, Inc.
Thu, Jul 16, 2026 at 07:50 PM
Liminatus Pharma, Inc. (LIMN:NASDAQ) jumped higher at $0.15, a gain of 29%. On Thu, Jul 16, 2026, LIMN:NASDAQ touched a New 2-Week High of $0.15. The stock got featured on our News Catalysts scanner on Tue, Jun 30, 2026 at 06:48 PM in the 'AGREEMENT' category. From Thu, Jul 02, 2026, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Thu, Jul 16, 2026 at $0.2 with a volume of 572M+.
About Liminatus Pharma, Inc. (LIMN:NASDAQ)
Liminatus Pharma, Inc. is pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies.
Top 10 Gainers:
- The GrowHub Limited (TGHL:NASDAQ), 86.62%
- Agape ATP Corporation (ATPC:NASDAQ), 66.67%
- Decent Holding Inc. (DXST:NASDAQ), 43.75%
- Twin Vee Powercats Co. (VEEE:NASDAQ), 36.07%
- CareDx, Inc (CDNA:NASDAQ), 35.6%
- ManpowerGroup Inc. (MAN:NYSE), 32.37%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 29%
- Highest Performances Holdings Inc. (MAAS:NASDAQ), 26.43%
- Distribution Solutions Group, Inc. (DSGR:NASDAQ), 25.29%
- LogProstyle Inc. (LGPS:NYSEMKT), 22.32%